{"id":"https://openalex.org/W2136808185","doi":"https://doi.org/10.31989/ffhd.v4i9.151","title":"Safety test of a supplement, 5-aminolevulinic acid phosphate with sodium ferrous citrate, in diabetic patients treated with oral hypoglycemic agents","display_name":"Safety test of a supplement, 5-aminolevulinic acid phosphate with sodium ferrous citrate, in diabetic patients treated with oral hypoglycemic agents","publication_year":2014,"publication_date":"2014-09-13","ids":{"openalex":"https://openalex.org/W2136808185","doi":"https://doi.org/10.31989/ffhd.v4i9.151","mag":"2136808185"},"language":"en","primary_location":{"id":"doi:10.31989/ffhd.v4i9.151","doi":"https://doi.org/10.31989/ffhd.v4i9.151","is_oa":true,"landing_page_url":"https://doi.org/10.31989/ffhd.v4i9.151","pdf_url":"https://ffhdj.com/index.php/ffhd/article/download/151/316","source":{"id":"https://openalex.org/S2764423505","display_name":"Functional Foods in Health and Disease","issn_l":"2160-3855","issn":["2160-3855","2378-7007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310316675","host_organization_name":"Food Science Publisher","host_organization_lineage":["https://openalex.org/P4310316675"],"host_organization_lineage_names":["Food Science Publisher"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Functional Foods in Health and Disease","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://ffhdj.com/index.php/ffhd/article/download/151/316","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049599825","display_name":"Naohide Yamashita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286826","display_name":"Institute of Medical Science, The University of Tokyo","ror":"https://ror.org/0376e0j29","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405286826","https://openalex.org/I74801974"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naohide Yamashita","raw_affiliation_strings":["Department of Advanced Medical Science, Institute of Medical Science, The University of \r\nTokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Advanced Medical Science, Institute of Medical Science, The University of \r\nTokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I4405286826","https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113638574","display_name":"Atai Watanabe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286826","display_name":"Institute of Medical Science, The University of Tokyo","ror":"https://ror.org/0376e0j29","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405286826","https://openalex.org/I74801974"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atai Watanabe","raw_affiliation_strings":["Department of Advanced Medical Science, Institute of Medical Science, The University of \r\nTokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Advanced Medical Science, Institute of Medical Science, The University of \r\nTokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I4405286826","https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000270883","display_name":"Hikaru Kondo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115801","display_name":"SBI Pharmaceuticals (Japan)","ror":"https://ror.org/028mhrr87","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210115801"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hikaru Kondo","raw_affiliation_strings":["SBI Pharmaceuticals Co., Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SBI Pharmaceuticals Co., Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I4210115801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073172050","display_name":"Satofumi Kawata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115801","display_name":"SBI Pharmaceuticals (Japan)","ror":"https://ror.org/028mhrr87","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210115801"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satofumi Kawata","raw_affiliation_strings":["SBI Pharmaceuticals Co., Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SBI Pharmaceuticals Co., Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I4210115801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042009785","display_name":"Tohru Tanaka","orcid":"https://orcid.org/0000-0001-7175-0114","observed_orcids":["https://orcid.org/0000-0001-7175-0114"]},"institutions":[{"id":"https://openalex.org/I4210115801","display_name":"SBI Pharmaceuticals (Japan)","ror":"https://ror.org/028mhrr87","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210115801"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tohru Tanaka","raw_affiliation_strings":["SBI Pharmaceuticals Co., Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SBI Pharmaceuticals Co., Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I4210115801"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021593247","display_name":"Motowo Nakajima","orcid":"https://orcid.org/0000-0001-7687-6365","observed_orcids":["https://orcid.org/0000-0001-7687-6365"]},"institutions":[{"id":"https://openalex.org/I4210115801","display_name":"SBI Pharmaceuticals (Japan)","ror":"https://ror.org/028mhrr87","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210115801"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Motowo Nakajima","raw_affiliation_strings":["SBI Pharmaceuticals Co., Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SBI Pharmaceuticals Co., Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I4210115801"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3124,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.4887693,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"4","issue":"9","first_page":"415","last_page":"415"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12441","display_name":"Porphyrin Metabolism and Disorders","score":0.16580000519752502,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12441","display_name":"Porphyrin Metabolism and Disorders","score":0.16580000519752502,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.10459999740123749,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.08749999850988388,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sodium-ferrous-citrate","display_name":"sodium ferrous citrate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8339999914169312},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.9860000014305115},{"id":"https://openalex.org/keywords/supplement-safety","display_name":"supplement safety","score":0.7129999995231628},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8199999928474426},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9470000267028809},{"id":"https://openalex.org/keywords/iron-supplementation","display_name":"iron supplementation","score":0.503000020980835},{"id":"https://openalex.org/keywords/glucose-lowering-effect","display_name":"glucose-lowering effect","score":0.4959999918937683},{"id":"https://openalex.org/keywords/prediabetes","display_name":"prediabetes","score":0.5809999704360962},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.597000002861023},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.4519999921321869},{"id":"https://openalex.org/keywords/greater-tokyo-area","display_name":"Tokyo metropolitan area","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8445332050323486},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7462372183799744},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6185281872749329},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6121271848678589},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5710430145263672},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5574375987052917},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.487045556306839},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.4588809907436371},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4081251621246338},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3684045970439911},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.27042263746261597},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.31989/ffhd.v4i9.151","doi":"https://doi.org/10.31989/ffhd.v4i9.151","is_oa":true,"landing_page_url":"https://doi.org/10.31989/ffhd.v4i9.151","pdf_url":"https://ffhdj.com/index.php/ffhd/article/download/151/316","source":{"id":"https://openalex.org/S2764423505","display_name":"Functional Foods in Health and Disease","issn_l":"2160-3855","issn":["2160-3855","2378-7007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310316675","host_organization_name":"Food Science Publisher","host_organization_lineage":["https://openalex.org/P4310316675"],"host_organization_lineage_names":["Food Science Publisher"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Functional Foods in Health and Disease","raw_type":"journal-article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.662.567","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.662.567","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://functionalfoodscenter.net/files/96281503.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.31989/ffhd.v4i9.151","doi":"https://doi.org/10.31989/ffhd.v4i9.151","is_oa":true,"landing_page_url":"https://doi.org/10.31989/ffhd.v4i9.151","pdf_url":"https://ffhdj.com/index.php/ffhd/article/download/151/316","source":{"id":"https://openalex.org/S2764423505","display_name":"Functional Foods in Health and Disease","issn_l":"2160-3855","issn":["2160-3855","2378-7007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310316675","host_organization_name":"Food Science Publisher","host_organization_lineage":["https://openalex.org/P4310316675"],"host_organization_lineage_names":["Food Science Publisher"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Functional Foods in Health and Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2136808185.pdf","grobid_xml":"https://content.openalex.org/works/W2136808185.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1518038365","https://openalex.org/W1656489757","https://openalex.org/W1966520620","https://openalex.org/W1998013298","https://openalex.org/W2012117258","https://openalex.org/W2012736422","https://openalex.org/W2028518937","https://openalex.org/W2028760856","https://openalex.org/W2035131905","https://openalex.org/W2044329567","https://openalex.org/W2056182647","https://openalex.org/W2056526409","https://openalex.org/W2067663978","https://openalex.org/W2077109510","https://openalex.org/W2079505490","https://openalex.org/W2084242756","https://openalex.org/W2087498225","https://openalex.org/W2087940120","https://openalex.org/W2088152201","https://openalex.org/W2091887970","https://openalex.org/W2099464099","https://openalex.org/W2104498985","https://openalex.org/W2126063102","https://openalex.org/W2133870133","https://openalex.org/W2140564842","https://openalex.org/W2156840781","https://openalex.org/W2159238556","https://openalex.org/W2168261002","https://openalex.org/W4239628108"],"related_works":["https://openalex.org/W4413533321","https://openalex.org/W2522771657","https://openalex.org/W7100186713","https://openalex.org/W3194424099","https://openalex.org/W4406615538","https://openalex.org/W2012736422","https://openalex.org/W2091887970","https://openalex.org/W2124576777","https://openalex.org/W2028518937","https://openalex.org/W2610512870"],"abstract_inverted_index":{"Objective:":[0],"This":[1,100],"study":[2,101],"aimed":[3],"to":[4,91,144,204,273],"examine":[5,92],"the":[6,35,117,126,186,213,234,252,265],"safety":[7,94,179],"of":[8,45,119,130,149,182,191],"5-aminolevulinic":[9,305],"acid":[10,306],"phosphate":[11],"(5-ALA)":[12],"with":[13,22,47,67,84,206,281,296],"sodium":[14,308],"ferrous":[15,309],"citrate":[16,310],"(SFC)":[17],"in":[18,34,54,97,211,216,227,232,244,251,259,264],"diabetic":[19,78,98,114,293],"patients":[20,79,115,294],"treated":[21,83,113,295],"one":[23],"or":[24,161],"more":[25],"oral":[26,312],"hypoglycemic":[27,183,313],"agents":[28],"(OHAs).Background:":[29],"Recent":[30],"intervention":[31],"studies":[32],"performed":[33],"USA":[36],"and":[37,95,108,121,132,154,180,196,218,248,286],"Japan":[38,131],"have":[39],"shown":[40],"that":[41,65],"a":[42,74,103,155,170,239,271,284],"nutritional":[43],"supplement":[44,76,160,289],"5-ALA":[46,66,205,255,268,280],"SFC":[48,68,207,282],"efficiently":[49],"reduced":[50],"blood":[51,193,217,320],"glucose":[52,194,321],"levels":[53],"pre-diabetic":[55],"population":[56],"without":[57],"any":[58],"adverse":[59],"events.":[60],"Thus,":[61],"it":[62,88],"was":[63,102,163,178,189,229,238,261,278],"anticipated":[64],"may":[69],"potentially":[70,287],"be":[71],"taken":[72,291],"as":[73],"beneficial":[75,288],"by":[77,169,292],"who":[80],"were":[81,123,135,141,208,221],"being":[82],"OHA":[85],"therapy.":[86],"Nevertheless,":[87],"is":[89,283],"important":[90],"its":[93],"efficacy":[96],"population.Methods:":[99],"prospective":[104],"single-blinded,":[105],"randomized,":[106],"placebo-controlled":[107],"parallel-group":[109],"comparison":[110],"study.":[111],"Medically":[112],"between":[116],"ages":[118],"30":[120],"75":[122],"recruited":[124],"from":[125],"Tokyo":[127],"metropolitan":[128],"area":[129],"45":[133],"subjects":[134,140],"selected":[136],"after":[137,275],"screening.":[138],"These":[139],"randomly":[142],"assigned":[143],"three":[145],"groups:":[146],"daily":[147],"intake":[148],"15mg":[150],"5-ALA,":[151,153],"50mg":[152],"placebo":[156,162],"(n=15,":[157],"respectively).":[158],"The":[159,175],"administered":[164],"for":[165],"12":[166],"weeks":[167,277],"followed":[168],"four":[171],"week":[172,250],"washout":[173],"period.":[174],"primary":[176],"endpoint":[177,188],"occurrence":[181],"attack,":[184],"while":[185],"secondary":[187],"changes":[190],"fasting":[192,319],"(FBG)":[195,322],"hemoglobin":[197,316],"A1c":[198,317],"(HbA1c).":[199],"Results:":[200],"Adverse":[201],"events":[202],"related":[203],"not":[209,222,230,262],"observed":[210,223,263],"all":[212,233],"groups.":[214,235],"Abnormalities":[215],"urine":[219],"tests":[220],"either.":[224],"Significant":[225,257],"decrease":[226,243,258,274],"FBG":[228],"detected":[231],"However,":[236],"there":[237],"small":[240],"but":[241],"significant":[242],"HbA1c":[245,260],"at":[246],"4":[247,276],"8":[249],"15":[253],"mg":[254,267],"group.":[256],"50":[266],"group,":[269],"although":[270],"tendency":[272],"apparent.Conclusion:":[279],"safe":[285],"if":[290],"OHAs.Trial":[297],"registration:":[298],"UMIN":[299],"000008038Key":[300],"words:":[301],"type":[302],"2":[303],"diabetes,":[304],"(5-ALA),":[307],"(SFC),":[311],"agent":[314],"(OHA),":[315],"(HbA1c),":[318]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}